2,036
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Pediatric Malignancies

Risk factors for impaired pulmonary function and cardiorespiratory fitness in very long-term adult survivors of childhood acute lymphoblastic leukemia after treatment with chemotherapy only*

ORCID Icon, , , , , , & show all
Pages 658-664 | Received 26 Sep 2017, Accepted 22 Dec 2017, Published online: 05 Jan 2018

References

  • Armstrong GT, Chen Y, Yasui Y, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med. 2016;374:833–842.
  • Essig S, Li Q, Chen Y, et al. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. The Lancet Oncology. 2014;15:841–851.
  • Huang TT, Hudson MM, Stokes DC, et al. Pulmonary outcomes in survivors of childhood cancer: a systematic review. Chest. 2011;140:881–901.
  • Skinner R, Kaplan R, Nathan PC. Renal and pulmonary late effects of cancer therapy. Semin Oncol. 2013;40:757–773.
  • Versluys AB, Bresters D. Pulmonary complications of childhood cancer treatment. Paediatr Respir Rev. 2016;17:63–70.
  • Armenian SH, Landier W, Francisco L, et al. Long-term pulmonary function in survivors of childhood cancer. JCO. 2015;33:1592–1600.
  • Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer. 2002;95:2431–2441.
  • Green DM, Zhu L, Wang M, et al. Pulmonary function after treatment for childhood cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE). Annals Ats. 2016;13:1575–1585.
  • Nysom K. Pulmonary function after treatment for acute lymphblastic leukaemia in childhood. Br J Cancer. 1998;78: 21–27.
  • Fulgoni P. Lung function in survivors of childhood acute lymphoblastic leukemia. Chest. 1999;116:1163–1167.
  • Jenney ME, Faragher EB, Jones PH, et al. Lung function and exercise capacity in survivors of childhood leukaemia. Med Pediatr Oncol. 1995;24:222–230.
  • Miller RW, Fusner JE, Fink RJ, et al. Pulmonary function abnormalities in long-term survivors of childhood cancer. Med Pediatr Oncol. 1986;14:202–207.
  • Turner-Gomes SO, Lands LC, Halton J, et al. Cardiorespiratory status after treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 1996;26:160–165.
  • Shaw NJ, Tweeddale PM, Eden OB. Pulmonary function in childhood leukaemia survivors. Med Pediatr Oncol. 1989;17:149–154.
  • Arpaci T, Kilicarslan Toruner E. Assessment of problems and symptoms in survivors of childhood acute lymphoblastic leukaemia. Eur J Cancer Care (Engl). 2016;25:1034–1043.
  • Tamnes CK, Zeller B, Amlien IK, et al. Cortical surface area and thickness in adult survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015;62:1027–1034.
  • Wilberg P, Kanellopoulos A, Ruud E, et al. Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7–40 years after diagnosis. Support Care Cancer. 2016;24:1497–1506.
  • Christiansen JR, Kanellopoulos A, Lund MB, et al. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015;62:1437–1443.
  • Kanellopoulos A, Andersson S, Zeller B, et al. Neurocognitive outcome in very long-term survivors of childhood acute lymphoblastic leukemia after treatment with chemotherapy only. Pediatr Blood Cancer. 2016;63:133–138.
  • Moe PJ. Childhood leukemia in Norway from 1963-1974 with special emphasis on own material. Acta Paediatrica Scandinavica. 1976;65:529–533.
  • Moe PJ. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Report on a national treatment program. Haematologia. 1981.
  • Magnani C, Pastore G, Coebergh JW, et al. Trends in survival after childhood cancer in Europe, 1978–1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer. 2006;42:1981–2005.
  • DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–271.
  • Fulbright JM. Review of cardiotoxicity in pediatric cancer patients: during and after therapy. Cardiol Res Pract. 2011;2011:942090
  • WHO. Global Strategy on Diet, Physical Activity and Health: World Health Organization; 2017 [cited 2017 Aug 17]. Available from: http://www.who.int/dietphysicalactivity/childhood_what/en/.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
  • Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–735.
  • Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511–522.
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Updated 2016. 2016.
  • American Thoracic S, American College of Chest P. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–277.
  • Jones NL. Clinical exercise testing. W. B. Saunders, 1982.
  • Kinnear W, Blakely J. A Practical guide to the interpretation of cardio-pulmonary exercise tests. New York (NY): Oxford University Press; 2014.
  • Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
  • McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Failure. 2012;14:803–869.
  • Sorensen PG, Rossing N, Rorth M. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity. Eur J Respir Dis. 1985;66:333–340.
  • Cooper AJ, White DA, Matthay RA. Drug-induced pulmonary disease. Am Rev Respir Dis. 1986;133:321–340.
  • Armstrong GT, Sklar CA, Hudson MM, et al. Long-term health status among survivors of childhood cancer: does sex matter? JCO. 2007;25:4477–4489.
  • Sansores RH, Pare PD, Abboud RT. Acute effect of cigarette smoking on the carbon monoxide diffusing capacity of the lung. Am Rev Respir Dis. 1992;146:951–958.
  • Jones LW, Eves ND, Haykowsky M, et al. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. The Lancet Oncology. 2008;9:757–765.
  • Norwegian Institute of Public Health. Overweight and obesity in Norway - Public health report 2014 [cited 2017 Aug 17]. Available from: https://www.fhi.no/en/op/public-health-report-2014/risk–protective-factors/overweight-and-obesity-in-norway—/.
  • Statistics Norway. Smoking habits, 2016 [cited 2017 Aug 17]. Available from: https://www.ssb.no/en/royk.
  • Demark-Wahnefried W, Aziz NM, Rowland JH, et al. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. JCO. 2005;23:5814–5830.
  • Kushi LH, Doyle C, McCullough M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62:30–67.
  • Ligibel J. Lifestyle factors in cancer survivorship. JCO. 2012;30:3697–3704.
  • Smith WA, Li C, Nottage KA, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer. 2014;120:2742–2750.
  • Oeffinger KC, van Leeuwen FE, Hodgson DC. Methods to assess adverse health-related outcomes in cancer survivors. Cancer. Epidemiol Biomarkers Prev. 2011;20:2022–2034.
  • van Dalen EC, van der Pal HJ, Kok WE, et al. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer. 2006;42:3191–3198.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.